Oakland-Jairath Score Validation

CompletedOBSERVATIONAL
Enrollment

344

Participants

Timeline

Start Date

November 25, 2019

Primary Completion Date

March 2, 2024

Study Completion Date

March 2, 2024

Conditions
Lower Gastrointestinal Bleeding
Interventions
OTHER

Oakland-Jairath Risk Score

Oakland and Jairath developed a clinical prediction rule for safe discharge among patients with LGIB using data from their UK National Audit. They defined safe discharge as the absence of rebleeding, blood transfusion, need for endoscopic/radiologic/surgical intervention for hemostasis, readmission with LGIB, and death and developed a seven variable risk score: age, sex, previous history of LGIB admission, presence of blood on digital rectal exam, heart rate, systolic blood pressure, and hemoglobin. Using a cut-off score ≤8, they reported excellent discrimination (AUC 0.84, 95% CI 0.82-0.86), good calibration, and a 95% probability of safe discharge.

Trial Locations (6)

T6G 2B7

University of Alberta Hospital, Edmonton

R3E 3P5

Health Science Centre, Winnipeg

B3H 2Y9

Nova Scotia Health - Victoria General Site, Halifax

N6A 5W9

London Health Sciences Centre, London

H2X 3E4

Centre hospitalier de l'Université de Montréal (CHUM), Montreal

H4A 3J1

McGill University Health Centre, Montreal

All Listed Sponsors
collaborator

Western University, Canada

OTHER

collaborator

Université de Montréal

OTHER

collaborator

University of Alberta

OTHER

collaborator

McGill University

OTHER

collaborator

University of Oxford

OTHER

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT03935360 - Oakland-Jairath Score Validation | Biotech Hunter | Biotech Hunter